Position in ELAN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$109,080,132
+$75,999,014 QoQ
Shares Held
4,432,350
+220.6% QoQ
Ownership
0.887%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#21
of 518 holders
Holding Since
Jun 2020
21 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MARSHALL WACE, LLP holds $609,159,561 across 30 Drug Manufacturers - Specialty & Generic names. ELAN ranks #2 (17.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HIMS |
Hims & Hers Health, Inc.
|
4,217,767 | $146,229,981 | |
| 2 | ELAN |
Elanco Animal Health Inc
This page
|
4,432,350 | $109,080,132 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
773,978 | $85,865,119 | |
| 4 | ALKS |
Alkermes plc.
|
969,954 | $50,825,589 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
270,754 | $45,632,878 | |
| 6 | RDY |
Dr Reddys Laboratories Ltd
|
2,025,356 | $29,347,408 | |
| 7 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
1,066,322 | $21,518,377 | |
| 8 | ZTS |
Zoetis Inc.
|
257,470 | $18,501,794 |
All Filings in ELAN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $109,080,132 | 4,432,350 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $33,081,118 | 1,382,412 | Shares | Other | 2026-05-15 | |
| 2025-09-30 | $7,398,308 | 367,344 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $5,073,198 | 355,266 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $5,350,600 | 509,581 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $2,032,336 | 167,823 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $5,853,950 | 398,499 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $19,987,209 | 1,385,115 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $112,051,023 | 6,882,741 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $23,508,385 | 1,577,744 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $3,409,519 | 303,338 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $31,149,451 | 3,096,367 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $8,817,199 | 938,000 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $10,811,998 | 884,779 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $7,815,768 | 629,796 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $6,527,622 | 332,533 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $1,707,198 | 65,435 | Shares | Other | 2022-05-16 | |
| 2021-06-30 | $18,136,729 | 522,823 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $3,079,026 | 104,551 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,318,748 | 42,998 | Shares | Sole | 2021-02-16 | |
| 2020-06-30 | $3,452,999 | 160,979 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||